Ulrike Dickmann - National Graphite CEO
| NGRC Stock | USD 0.07 0.02 54.55% |
CEO
Mrs. Ulrike Dickmann is President, Chief Executive Officer, Director of the company. Mrs is a Director and the President and CEO of the Company and its whollyowned subsidiary, Biotech Development Corporationration Mrs. Dickmann has more 40 years of experience both in the field of health professions, as well as in the financial industry. Prior joining the Company, Mrs. Dickmann was an independent investment advisor for qualified private investors in selected areas of Life Science and Healthcare. From that she worked as pharmaceutical representative and consultant for HoffmannLa Roche and Baxter Travenol, and was medical radiology assistant from 1973 through 1987. On September 17, 2015, the Company entered into an Employment Agreement with Ms. Dickmann, the President and Chief Executive Officer of the Company. The term of Employment Agreement began on September 17, 2015, and shall continue for a period of three years until September 16, 2018, unless terminated earlier pursuant to other provisions of the Agreement. During the Employment Period, the Company agrees to pay Ms. Dickmann a Base Salary of 180, 000 per year. Pursuant to the agreement, Ms. Dickmann may be terminated for cause as defined and she is subject to confidentiality, noncompete and nonsolicitation restrictions. since 2014.
| Age | 62 |
| Tenure | 10 years |
| Phone | 49 172 6544175 |
| Web | http://www.nationalgraphitecorp.com |
National Graphite Management Efficiency
The company has return on total asset (ROA) of (75.8021) % which means that it has lost $75.8021 on every $100 spent on assets. This is way below average. National Graphite's management efficiency ratios could be used to measure how well National Graphite manages its routine affairs as well as how well it operates its assets and liabilities. National Graphite Corp., through its subsidiary, Biotech Development Corp., operates as a biopharmaceutical riskcost-sharing company. National Graphite Corp. was founded in 2006 and is based in Duesseldorf, Germany. NATIONAL GRAPHITE is traded on OTC Exchange in the United States. National Graphite Corp [NGRC] is a Pink Sheet which is traded between brokers as part of OTC trading.Management Performance
| Return On Asset | -75.8 |
National Graphite Corp Management Team
Elected by the shareholders, the National Graphite's board of directors comprises two types of representatives: National Graphite inside directors who are chosen from within the company, and outside directors, selected externally and held independent of National. The board's role is to monitor National Graphite's management team and ensure that shareholders' interests are well served. National Graphite's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, National Graphite's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Verena Becchio, Secretary and Director | ||
| Ulrike Dickmann, President CEO, Director of the Company and Biotech Development Corporate | ||
| M Dickmann, President, Officer |
National Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is National Graphite a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -75.8 | |||
| Current Valuation | 5.36 M | |||
| Shares Outstanding | 154.31 M | |||
| Shares Owned By Insiders | 36.29 % | |||
| Price To Earning | (1.60) X | |||
| EBITDA | (1.58 M) | |||
| Net Income | (1.97 M) | |||
| Cash And Equivalents | 24.17 K | |||
| Current Ratio | 0.02 X | |||
| Book Value Per Share | (0.02) X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in National Graphite Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Complementary Tools for National Pink Sheet analysis
When running National Graphite's price analysis, check to measure National Graphite's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy National Graphite is operating at the current time. Most of National Graphite's value examination focuses on studying past and present price action to predict the probability of National Graphite's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move National Graphite's price. Additionally, you may evaluate how the addition of National Graphite to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |